
    
      A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate
      the Safety and Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal
      Spray 50mcg and 100mcg for 12 Weeks in Pediatric Subjects Ages 2 to <12 Years with Perennial
      Allergic Rhinitis (PAR)
    
  